U.S. investors cut their use of leverage in July, marking the first month since the onset of the pandemic that saw a reduction in the use of margin debt to buy securities like stocks, potentially a warning sign for markets buoyed by heavy use of borrowed money.
Pfizer CEO Albert Bourla told Fox News the company has a system in place to turn around a variant-specific jab within 95 days in the likelihood a vaccine-resistant COVID strain emerges, but experts warn that strategy will backfire.
US securities regulators plan to require additional information from Chinese companies seeking to go public on American exchanges, saying the move will protect domestic investors.
Global money managers funneled nearly $1 trillion into U.S. financial assets in the first half, signaling the American economy is primed to dominate post-COVID markets.